GlaxoSmithKline Pharmaceuticals has fixed 30 May 2025 as record date for determining entitlement of members to final dividend for the financial year ended 31st March 2025. The dividend, if approved, shall be paid on or after 30 June 2025.
Powered by Capital Market - Live News